CHRONIC LIVER DISEASE

This study tests whether giving copper supplements to people with cirrhosis (scarred liver) and low copper levels can improve liver function and reduce infections. About 30 adults with cirrhosis and low blood copper will receive either copper or a placebo for several weeks, then …

This phase 3 study tests a treatment called LAENNEC, made from human placenta, for people with chronic liver disease. It compares giving the drug through an IV drip versus a standard injection under the skin. The main goal is to see if the IV form lowers liver enzyme (ALT) levels…

This study is testing a new, non-invasive ultrasound exam called Hepatoscope to screen for liver scarring (fibrosis) and fatty liver in people at risk. About 200 patients with risk factors like diabetes or abnormal liver tests will get the scan. If the scan shows significant stif…

This study compares standard ultrasound monitoring to ultrasound plus a short, 10-minute MRI (Fast-MRI) for detecting early-stage liver cancer in people with cirrhosis who are at high risk. About 944 participants will be followed for several years to see which method finds more e…

This study is testing a new way to measure liver stiffness and fat using an endoscope with ultrasound (EUS-SWE). It will compare this method to standard liver biopsy and FibroScan in 300 adults with suspected liver disease. The goal is to see if this new technique can accurately …

This study is testing a blood test called hepatomiR to see if it can predict when people with chronic liver disease will develop serious complications like fluid buildup in the belly, bleeding in the stomach, or confusion. The goal is to better understand what leads to these even…

This study looks at the social and economic challenges faced by people with chronic liver disease, such as trouble paying for food or housing. Researchers will survey 400 patients and their doctors to find out what needs are most common and whether patients want their medical tea…